๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Randomized sequential hormonal therapy vs adrenalectomy for metastatic breast carcinoma

โœ Scribed by Dr. Robert H. Yonemoto; Matthew S. C. Tan; Ralph L. Byron; Daniel U. Riihimaki; Joseph Keating; Warren Jacobs

Publisher
John Wiley and Sons
Year
1977
Tongue
English
Weight
632 KB
Volume
39
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

A randomized Phase II trial of two dosag
A randomized Phase II trial of two dosage levels of letrozole as third-line hormonal therapy for women with metastatic breast carcinoma
โœ James N. Ingle; Patricia A. Johnson; Vera J. Suman; James B. Gerstner; James A. ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 88 KB ๐Ÿ‘ 2 views

letrozole dosage levels, 0.5 mg and 2.5 mg per day, was performed. Eligibility requirements included failure on two prior hormonal therapies and measurable

Concomitant versus sequential administra
Concomitant versus sequential administration of epirubicin and paclitaxel as first-line therapy in metastatic breast carcinoma : Results from the Gruppo Oncologico Nord Ovest Randomized Trial
โœ Pier Franco Conte; Valentina Guarneri; Paolo Bruzzi; Tiziana Prochilo; Barbara S ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 111 KB

## Abstract ## BACKGROUND The authors performed a randomized trial comprising patients with metastatic breast carcinoma (MBC). They used a noninferiority design to evaluate whether the results of sequential administration of epirubicin and paclitaxel were not markedly worse than the concomitant ad